File:PMC5381059 12929 2017 329 Fig2 HTML.png
PMC5381059_12929_2017_329_Fig2_HTML.png (512 × 383 pixels, file size: 223 KB, MIME type: image/png)
License
CC0 1.0 Universal (CC0 1.0) Public Domain Dedication
- &
Attribution 4.0 International (CC BY 4.0)
Summary
Author:Yoshiko Iwai, Junzo Hamanishi,Kenji Chamoto, and Tasuku Honjo,Department of Molecular Biology, School of Medicine, University of Occupational and Environmental Health Japan,Department of Immunology and Genomic Medicine, Graduate School of Medicine, Kyoto University, Department of Gynecology and Obstetrics, Graduate School of Medicine, Kyoto University(Openi/National Library of medicine)Source:https://openi.nlm.nih.gov/detailedresult?img=PMC5381059_12929_2017_329_Fig2_HTML&query=Atezolizumab&it=xg&req=4&npos=2 Description:Fig2: History of PD-1 research. Abbreviations: FIM, first in man; approved, FDA-approved; NCT, “National Clinical Trial” registry number in ClinicalTrials.gov in the United States; FIM Pembrolizumab (P07990/MK-3475-001/KEYNOTE-001), NCT01295827; FIM Pidilizumab (CT-011), NCT00532259; FIM BMS-936559 (MDX-1105), NCT00729664; FIM Atezolizumab, NCT01693562; FIM Durvalumab (MEDI4736), NCT01693562; FIM Avelumab, NCT01772004
File history
Click on a date/time to view the file as it appeared at that time.
Date/Time | Thumbnail | Dimensions | User | Comment | |
---|---|---|---|---|---|
current | 23:26, 20 January 2022 | 512 × 383 (223 KB) | Ozzie10aaaa (talk | contribs) | Author:Yoshiko Iwai, Junzo Hamanishi,Kenji Chamoto, and Tasuku Honjo,Department of Molecular Biology, School of Medicine, University of Occupational and Environmental Health Japan,Department of Immunology and Genomic Medicine, Graduate School of Medicine, Kyoto University, Department of Gynecology and Obstetrics, Graduate School of Medicine, Kyoto University(Openi/National Library of medicine)Source:https://openi.nlm.nih.gov/detailedresult?img=PMC5381059_12929_2017_329_Fig2_HTML&query=Atezoli... |
You cannot overwrite this file.
File usage
There are no pages that use this file.